Cart 0

Home ALKtALK Shop

Join

Research Grants ALK Research Library Cutting Edge Trials Clinical Trials ALK Life Study

Get Support What is ALK Treatment & Resources 2nd Opinion Program ALK Summit 2024

About Us Finances Alliances Contact Press

Blog Newsletters Prospectus Annual Report

Donate Ways to Give Fundraise with ALK+

Cart 0

Home Research Research Grants ALK Research Library Cutting Edge Trials Clinical Trials ALK Life Study Patients Get Support What is ALK Treatment & Resources 2nd Opinion Program ALK Summit 2024 About About Us Finances Alliances Contact Press ALKtALK Media Blog Newsletters Prospectus Annual Report Shop

Donate Donate Ways to Give Fundraise with ALK+ Join

Posts tagged Dagogo-Jack

Dr. Jessica Lin and Dr. Ibiayi Dagogo-Jack at ALKtALK

Dr. Jessica Lin and Dr. Ibiayi Dogogo-Jack explain their new clinical trial combining Lorlatinib with a SHP2 inhibitor, TNO155.

Kirk SmithApril 17, 2021ALKtALK, ALKTALK, Lin, Dagogo-Jack

Donate

Join Support Group

info@alkpositive.org

ALK Positive, Inc. 6595 Roswell Road;

Suite G2310 Atlanta, GA 30328

Please send checks to:

ALK LOCKBOX, P.O. Box 24960 New York, New York 10087-4960

Email Address

We respect your privacy.

Thank you!

info@alkpositive.org

Hours

Mon Open

Tue Open

Wed Open

Thu Open

Fri Open

Sat Open

Sun Open

The content on the ALK Positive website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. © ALK Positive, Inc. All Rights Reserved